Peran Penambahan Misoprostol pada Penatalaksanaan Aktif Kala Tiga dalam Menurunkan Perdarahan Pasca Persalinan

https://doi.org/10.22146/jkr.35422

Puti Lenggo Geni(1*), Irwan Taufiqur Rachman(2), Heru Pradjatmo(3)

(1) Departement Obstetri dan Ginekologi, FKKMK UGM
(2) Departement Obstetri dan Ginekologi, FKKMK UGM
(3) Departement Obstetri dan Ginekologi, FKKMK UGM
(*) Corresponding Author

Abstract


Background: Postpartum haemorrhage is the leading cause of maternal mortality in both developed and developing countries, which is almost 80 % due to the failure of the uterus to contract. Misoprostol is a powerful uterotonic agent used as an alternative in preventing postpartum haemorrhage.

Objective: The purpose of this study was to determine whether administration of misoprostol adjunctive therapy in active management of the third stage of labor influenced postpartum blood loss.

Method: This study was a non-blinding randomized controlled trial that divided subjects into two groups. The treatment group was the group who received misoprostol 600 mcg orally for adjunctive treatment in active management of the third stage of labor and the control group did not receive misoprostol, each group also got routine oxytocin 10 IU intramuscularly. Both group were assessed of the number of blood loss in the fourth stage of labor, decreased levels of hemoglobin and hematocrit within 24 hours after delivery. Chi square test was conducted to determine the strength of the relationship between the two groups.

Result and Discussion: The study recruited 104 subjects, there were significant difference for the mean number of blood loss in the fourth stage of labor and the decrease in hemoglobin levels within 24 hours of postpartum between treatment and control group (OR 2.45; 95% CI 1.05-5.71, p=0.04), (OR 2.99; 95% CI 1.26-7.11, p=0.01). The mean of the decreasing hematocrit levels was statistically not significant between the two groups (OR 0.87; 95% CI 0.38-1.99, p=0.75).

Conclusion: The addition of misoprostol to the routine active management of the third stage of labor was statistically significant to decrease amount of postpartum blood loss.

Keywords: misoprostol, active management of the third stage of labor, postpartum blood loss, postpartum hemorrhage.


Keywords


misoprostol; active management of the third stage of labor; postpartum blood loss; postpartum hemorrhage.

Full Text:

PDF


References

Agustin C, Anibal N, Anyeli R, Roberto R. 2013. Misoprostol to Reduce Intraoperative and Postoperative Hemorrhage During Cesarean Delivery: A Systematic Review and Metanalysis. In: American Journal of Obstetrics and Gynecology; Vol 209. 40: 1-17.

Badan Pusat Statistik (BPS), Badan Koordinasi Keluarga Berencana Nasional (BKKBN), Kementrian Kesehatan, ICF Internasional. 2012. Indonesia Demographic and Health Survey J: BPS, BKKBN, Kemenkes dan ICF Internasional. Jakarta.

Chaudhuri P, Majumdar A. 2016. A randomized trial of sublingual misoprostol to augment routine third-stage management among women at risk of postpartum hemorrhage. Int J Gynaecol Obstet; 132(2):191-5.

Cunningham FG, Leveno KJ, Bloom SL, Spong CY, Dashe JS, Hoffman BL, Cassey BM, Sheffield JS. 2014. Obstetrical Hemorrhage. In: Williams Obstetrics 24th Edition. United States; Chap 41: 780821.

Fekih M, Jnifene A, Fathallah K, Ben Regaya L, Memmi A, Bouguizene S, Chaieb A, Bibi M, Khairi H 2009. Benefit of Misoprostol for Prevention of Postpartum Hemorrhage in Cesarean Section: A Randomized Controlled Trial.J gynecol Obstet Bio Reprod; 38(7): 588-593

Hofmeyr G J, Fawole B, Mugerwa K, Godi NP, Blignaut Q, Mangesi L, ingata M, Brady L, Blum J 2011. Administration of 400 mcg of Misoprostol to Augment Routine Active Management of The Third Stage of Labor. Int J Gynaecol Obstet; 112(2) 98102.

Hashim N, Naqvi S, Majida K, Hassan FJ 2012. Primiparity as an intrapartum obstetric risk factor. J Pak Med Assoc; 62(07):694-8.

Lumbiganon P, Hofmeyr J, Gulmezoglu AM, Pnol A, Villar J. 1999. Misoprostol dose- related shivering and pyrexia in the third stage of labour. WHO Collaborative Trial of Misoprostol in the Management of the Third Stage of Labour. Br J Obstet Gynaecol; 106(4):304-8.

Quinto L, Aponte JJ, Menendez C, Sacarlal J, Alde P, Espasa M et al 2006. Relationship between haemoglobin and haematocrit in the definition of anemia. Trop Med Int Health; 11(8):1295-302



DOI: https://doi.org/10.22146/jkr.35422

Article Metrics

Abstract views : 683 | views : 4781

Refbacks

  • There are currently no refbacks.


Copyright (c) 2017 Jurnal Kesehatan Reproduksi



Jurnal Kesehatan Reproduksi Indexed by:

 



SEKRETARIAT JURNAL KESEHATAN REPRODUKSI
Departemen Obstetri dan Ginekologi, FK-KMK, UGM/RS Dr. Sardjito
Jl. Kesehatan No. 1, Sekip Utara, Yogyakarta 55281
Tlp: (0274) 511329 / Faks: (0274) 544003
Email: jurnal.kesehatanreproduksi@ugm.ac.id
Cp: Dwi Astuti +6281802698043